Prospective intervention study for drainage of subretinal hemorrhage using tissue plasminogen activator

Prospective intervention study for drainage of subretinal hemorrhage using tissue plasminogen activator - Prospective intervention study for drainage of subretinal hemorrhage using tissue plasminogen activator

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000019668

Enrollment

Registered

2015-11-06

Start date

2015-10-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

subretinal hemorrhage

Interventions

injection to vitreous cavity 45000IU/0.3ml injection to subretinal cavity 3000/0.02ml-30000/0.2ml

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patient who fills all following clinical features are objected. 1) subretinal hemorrhage 2) more than 16-year-old person 3) male and female 4) well informed-consented person 5) hospitalizing and foreignness 6) even participates in other clinical study or not

Exclusion criteria

Exclusion criteria: Patient who fills any following clinical features are not applicable. 1) the patient who judged that prescription wasn't desirable for other ocular diseases or whole body diseases 2) the patient who judged unsuitable as a subject

Design outcomes

Primary

Measure	Time frame
The degree of improvement of postoperative clinical presentations	—

Countries

Japan

Contacts

Public ContactKazuhiro Kimura

Yamaguchi University Hospital ophthalmology

k.kimura@yamaguchi-u.ac.jp0836-22-2278

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026